Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …

Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Colorectal cancer (CRC) is the second most common cause of cancer death in the United
States. Every 3 years, the American Cancer Society provides an update of CRC occurrence …

The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel rise in the use of biomarkers to guide …

Background Colorectal cancer (CRC) is still a leading cause of cancer-related deaths in the
United States and worldwide, despite recent improvements in cancer management. CRC …

Background Staphylococcus aureus is among the most common human pathogens, with
therapy complicated by the epidemic spread of methicillin-resistant Staphylococcus aureus …

Over the past two decades, the molecular characterization of metastatic colorectal cancer
(mCRC) has been revolutionized by the routine implementation of RAS and BRAF tests. As …

With the development of genome sequencing, the role of molecular targeted therapy in
cancer is becoming increasingly important. However, genetic testing remains expensive …

Background The aim of this study was to develop a prediction model for 10-year overall
survival (OS) after resection of colorectal liver metastasis (CRLM) based on patient, tumour …

Background A considerable number of patients with stage II/III colorectal cancer (CRC) will
relapse within 5 years after surgery, which is a leading cause of death in early-stage CRC …